27th April the market was informed that BioGaia guaranteed the issue in the former subsidiary IBT up to an amount of SEK 38 million.

Today it was announced that the rights issue in IBT was fully subscribed. Hence, the underwriting guarantee will not be utilized.


Latest press releases from BioGaia
2017-05-17 BioGaia’s probiotic effective in treating abdominal pain in children 
2016-05-11 Annual General Meeting of BioGaia
2016-05-10 BioGaia AB – Interim management statement 1 January - 31 March 2016

BioGaia has published this information in accordance with the Swedish Securities Act. The information was issued for publication on 26 May 2016, 8:30 am CET.